Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
Hepatocellular carcinoma (HCC) is one of the leading indications for liver transplantation and has been the treatment of choice due to the oncologic benefit for patients with advanced chronic liver disease (AdvCLD) and small tumors for the last 25 years. For HCC patients undergoing liver transplanta...
Main Authors: | Brianna Ruch, Josiah Wagler, Kayla Kumm, Chi Zhang, Nitin N. Katariya, Mauricio Garcia-Saenz-de-Sicilia, Emmanouil Giorgakis, Amit K. Mathur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/29/10/593 |
Similar Items
-
Clinical value of alpha-fetoprotein: alpha-fetoprotein-L3 isoform ratio and des-γ-carboxyprothrombin in early diagnosis of HBV-related hepatocellular carcinoma
by: Duan Jianping, Du Lei, Song Ting, Liu Zhensheng
Published: (2023-08-01) -
Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative study
by: Ahmed Haitham Abduljabbar
Published: (2023-02-01) -
The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels
by: Chia-Chu Fu, et al.
Published: (2023-07-01) -
Aggressive Gastric Carcinoma Producing Alpha-Fetoprotein: A Case Report and Review of the Literature
by: A. Lunghi, et al.
Published: (2014-01-01) -
Utility of Alpha-Fetoprotein and Ultrasound in the Diagnosis and Prognosis of Patients with Hepatocellular Liver Cancer
by: Huang D, et al.
Published: (2024-04-01)